ISHARES TR - U.S. PHARMA ETF (IHE)

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / U.S. PHARMA ETF
Total 13F shares
2,310,854
Share change
-228,250
Total reported value
$404,115,318
Price per share
$174.82
Number of holders
119
Value change
-$39,781,267
Number of buys
63
Number of sells
43

Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q2 2015

As of 30 Jun 2015 ISHARES TR - U.S. PHARMA ETF (IHE) had 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 2,310,854 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, Brookstone Capital Management, ARS Wealth Advisors, LLC, LPL Financial LLC, BROWN ADVISORY INC, RAYMOND JAMES & ASSOCIATES, and Braver Wealth Management, LLC.
This table shows 119 institutional shareholders of the security as of 30 Jun 2015.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.